NewsRoom Articles - Page 23 of 154 - PsychedelicNewsWire (PNW)

WednesdaySep 20, 2023 1:13 pm

Reports Say MDMA Could Get FDA Consideration for Approval Next Year

New research has found that patients suffering from moderate to severe PTSD may experience a reduction in their symptoms following treatment with MDMA. The study, which was sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS), published its findings in the “Nature” journal. Rick Doblin, president and founder of Multidisciplinary Association for Psychedelic Studies (MAPS), believes that MDMA-assisted therapy is on course for approval by the Food and Drug Administration (FDA) in 2024, thanks to the efforts of many therapists, participants and donors. The study, which involved a randomized, placebo-controlled, double-blinded trial, recruited 104 individuals with PTSD who received either…

TuesdaySep 19, 2023 2:24 pm

How Psychedelics Treat Brain Injuries

Psychedelics have exploded in popularity in recent years thanks to a growing body of literature that indicates they may be potent mental-health treatments. Several studies have found that when psychedelics such as LSD, psilocybin and MDMA are paired with traditional talk therapy, they can provide long-term relief against mental conditions, including post-traumatic stress disorder (PTSD), anxiety and severe depression. Like medical cannabis, psychedelics are emerging from the specter of decades of federal prohibition due to a spike in research that connected hallucinogens to several mental-health benefits. Researchers are now looking into the possibility of using psychedelics to treat brain injuries…

MondaySep 18, 2023 12:11 pm

Study Finds Psychedelic Users Lower Cocaine, Alcohol Intake

Recent research published in the “International Journal of Mental Health and Addiction” has indicated that psychedelic use may result in reduced cocaine intake. The study found that while psychedelic users reported either reducing or completely stopping their intake of cocaine, antidepressants and alcohol, their use of tobacco and cannabis products went up. As psychedelics have been illegal at the state and federal levels for the past several decades, their use has been limited to a small niche community of psychonauts. However, a recent surge in psychedelic research revealed that hallucinogens have the potential to treat a myriad of mental-health disorders…

FridaySep 15, 2023 2:43 pm

Exploring Effects of Simultaneous Opioid, Psychedelic Use for Chronic Pain

Recent research investigating the interaction between psychedelics and opioids has found that using the two together to treat chronic pain may not be a good idea. Opioids have been the go-to treatment for pain disorders for a long time, but they have lost popularity over the past decade, especially as the public became increasingly aware of their side effects amid a deadly opioid crisis. As a wave of drug reform swept across the country, cannabis emerged as one of the most popular alternative treatments for chronic pain because it is generally safer to use and doesn’t have side effects such…

ThursdaySep 14, 2023 9:00 am

Study Shows Psilocybin Combats Stress by Triggering Rise in Stress Hormone

A new study published in the “ACS Pharmacology & Translational Science” journal has revealed that psychedelics such as psilocybin may combat stress by triggering a temporary increase in stress hormones. The research provides more insight into the potential underlying mechanisms that may allow psychedelics to deliver various mental health benefits. Psilocybin is a psychedelic compound that occurs naturally in certain mushroom species. It is converted into the active form psilocin when ingested and mainly interacts with serotonin receptors in the brain. The traditional “psychedelic experience’” occurs when psilocin interacts with the serotonin 2A receptor subtype and induces feelings of altered…

WednesdaySep 13, 2023 1:19 pm

Michigan Lawmakers Want Congress to Make Psychedelic Research a Priority

Michigan lawmakers want the U.S. Congress, the Department of Veteran Affairs (VA) and the Department of Defense (DOD) to make psychedelic research a priority. Policymakers are calling on Congress to prioritize investment in the research of “nontechnology treatment options” such as psychedelics to expand treatment options for psychological trauma in active and retired military service members. Last week, the Michigan Senate passed a resolution stating that controlled psychedelic clinical trials paired with approaches such as buddy-to-buddy programs, expanded access to service animals and outdoor therapy have “shown promise” as alternative mental-health treatments for veterans. Since House lawmakers advanced the same…

TuesdaySep 12, 2023 10:55 am

Oregon Opens First Nationwide Addiction Treatment Center Leveraging Psilocybin

A collective of trained and experienced psilocybin facilitators in Oregon has launched the country’s first psilocybin-assisted recovery program for addicts. The program is the result of a partnership between Nexus Center for Consciousness and a team of licensed psilocybin facilitators called Moksha Journeys. The program will provide a 28-day retreat for adults looking for alternative addiction-recovery treatments. In addition, the program will offer treatment services such as family therapy, guest counseling, movement coaching, sound therapy and acupuncture treatment as well as outdoor recreational services such as hiking southern Oregon’s forests. The Oregon psilocybin-assisted recovery program will hold its first retreat…

MondaySep 11, 2023 2:42 pm

California House Passes Psychedelics Bill, Resends to Senate

California Assembly members have approved a psychedelic legalization measure passed by the Senate before sending it back to the Senate for discussions on recent amendments. The bill could potentially land on Governor Gavin Newsom’s desk once it advances through the Senate, putting California on track to legalize psychedelic use for eligible adults. Senator Scott Wiener introduced the measure to legalize the cultivation and possession of small amounts of entheogenic fungi and plants for adults aged 21 years and older. The California Assembly passed the psychedelic legalization measure in a 42 to 11 vote. Wiener said Californian first responders, veterans and…

FridaySep 08, 2023 2:17 pm

Lobby Group Suggests Trippers Need to Advise Europe on Psychedelic Policy Reform

With Europe embarking on psychedelic reform and the potential legalization of therapeutic psychedelics, a lobby group comprised of industry players and developers says regulators should leverage knowledge from experienced psychedelic users to inform their decisions. In a document sent to the European Medicines Agency (EMA), the Psychedelic Access Research and European Alliance (PAREA) said the regional bloc needs a standard voice of authority for therapeutic psychedelic use, which includes experienced psychedelic users. The lobby group called for authorities to create a multidisciplinary advisory body to provide professionals and regulators with guidance on best practices for psychedelic-assisted therapies amid the ongoing…

FridaySep 08, 2023 10:30 am

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Is ‘One to Watch’

In July 2023, LSDI launched Twilight, a new sleep aid product The company in July 2023 announced its acquisition of SANA-013 from Wesana Health; SANA-013 is being developed for the treatment of several mental health and central nervous system conditions LSDI in May 2023 launched its new Mindful product line designed to enhance well-being and promote a mindful approach to life Also in May 2023, the company announced a partnership with non-profit TheraPsil to advance medical psilocybin access and research LSDI announced in April 2023 that its board had approved the repurchase of up to 500,000 shares of its Class…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000